Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zhengye Biotechnology Holding Ltd. ( (ZYBT) ) just unveiled an announcement.
On March 24, 2026, Zhengye Biotechnology Holding Limited held its Annual General Meeting of Shareholders in Jilin City, with investors also able to attend virtually. Shareholders representing a substantial majority of the 47.39 million outstanding ordinary shares were present in person or by proxy, ensuring a quorum for formal business.
At the meeting, investors approved all resolutions, including the election of two new directors, the re-election of certain current directors, a share reclassification, and a share consolidation. Shareholders also passed a special resolution to adopt a new memorandum and articles of association, signaling board-backed corporate governance and capital structure changes that may influence the company’s strategic flexibility and market positioning going forward.
The most recent analyst rating on (ZYBT) stock is a Hold with a $0.84 price target. To see the full list of analyst forecasts on Zhengye Biotechnology Holding Ltd. stock, see the ZYBT Stock Forecast page.
Spark’s Take on ZYBT Stock
According to Spark, TipRanks’ AI Analyst, ZYBT is a Neutral.
The score is held back primarily by very weak technicals (price below all key moving averages, negative MACD, RSI at 17) and pressured cash flow (free cash flow down 63.72%). A moderately stable balance sheet (debt-to-equity 0.30) partially offsets these risks, while valuation is difficult to support due to a negative P/E and no dividend yield provided.
To see Spark’s full report on ZYBT stock, click here.
More about Zhengye Biotechnology Holding Ltd.
Zhengye Biotechnology Holding Limited is a China-based biotechnology company headquartered in Jilin City, Jilin Province. The company is listed in the United States as a foreign private issuer and has its principal executive offices in the Jilin Economic & Technical Development Zone, operating within the broader life sciences and biotech sector.
Average Trading Volume: 213,424
Technical Sentiment Signal: Strong Sell
Current Market Cap: $47.39M
See more insights into ZYBT stock on TipRanks’ Stock Analysis page.